Comparative effectiveness and duration of protection of ChAdOx1, CoronaVac, BNT162b2, mRNA-1273, and Ad26.COV2.S COVID-19 vaccines for symptomatic and hospitalized Mu, Delta, and Omicron: A test-negative case-control study
Paternina-Caicedo, Angel, Quevedo, David Santiago, Ríos, Diana Sofía, Moyano, Diane, Alvis-Guzmán, Nelson, Alviz-Zakzuk, Nelson Rafael, Salcedo, Fernando, Moyano, Lina, Ramírez-Suarez, Javier, Smith, Adrian D., De la Hoz-Restrepo, Fernando
Published in Vaccine (06.10.2023)
Published in Vaccine (06.10.2023)
Get full text
Journal Article
Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron
Paternina-Caicedo, Angel, Quevedo, David Santiago, Ríos, Diana Sofía, Moyano, Diane, Alvis-Guzmán, Nelson, Alviz-Zakzuk, Nelson Rafael, Salcedo, Fernando, Ramírez-Suarez, Javier, Smith, Adrian D., De la Hoz-Restrepo, Fernando
Published in The Journal of infection (01.06.2024)
Published in The Journal of infection (01.06.2024)
Get full text
Journal Article